Opko Health Inc (OPK) - Total Assets

Latest as of September 2025: $2.00 Billion USD

Based on the latest financial reports, Opko Health Inc (OPK) holds total assets worth $2.00 Billion USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Opko Health Inc for net asset value and shareholders' equity analysis.

Opko Health Inc - Total Assets Trend (1995–2024)

This chart illustrates how Opko Health Inc's total assets have evolved over time, based on quarterly financial data.

Opko Health Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Opko Health Inc's total assets of $2.00 Billion consist of 30.1% current assets and 69.9% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 19.6%
Accounts Receivable $152.05 Million 6.9%
Inventory $56.80 Million 2.6%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $811.61 Million 36.9%
Goodwill $529.25 Million 24.1%

Asset Composition Trend (1995–2024)

This chart illustrates how Opko Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Opko Health Inc market cap and net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Opko Health Inc's current assets represent 30.1% of total assets in 2024, a decrease from 83.1% in 1995.
  • Cash Position: Cash and equivalents constituted 19.6% of total assets in 2024, down from 83.1% in 1995.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, an increase from 13.0% in 1995.
  • Asset Diversification: The largest asset category is intangible assets at 36.9% of total assets.

Opko Health Inc Competitors by Total Assets

Key competitors of Opko Health Inc based on total assets are shown below.

Company Country Total Assets
Sonic Healthcare Ltd
AU:SHL
Australia AU$17.03 Billion
Eurofins-Cerep SA
PA:ALECR
France €84.58 Million
Inoviq Ltd
AU:IIQ
Australia AU$24.52 Million
Bcal Diagnostics Ltd
AU:BDX
Australia AU$7.17 Million
Imagion Biosystems Ltd
AU:IBX
Australia AU$932.48K
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million
Monash Ivf Group Ltd
AU:MVF
Australia AU$510.21 Million

Opko Health Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.70 2.97 1.39
Quick Ratio 3.32 2.69 1.04
Cash Ratio 0.00 0.00 0.00
Working Capital $457.81 Million $417.98 Million $147.70 Million

Opko Health Inc - Advanced Valuation Insights

This section examines the relationship between Opko Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.71
Latest Market Cap to Assets Ratio 0.38
Asset Growth Rate (YoY) 9.4%
Total Assets $2.20 Billion
Market Capitalization $844.47 Million USD

Valuation Analysis

Below Book Valuation: The market values Opko Health Inc's assets below their book value (0.38x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Opko Health Inc's assets grew by 9.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Opko Health Inc (1995–2024)

The table below shows the annual total assets of Opko Health Inc from 1995 to 2024.

Year Total Assets Change
2024-12-31 $2.20 Billion +9.37%
2023-12-31 $2.01 Billion -7.18%
2022-12-31 $2.17 Billion -9.69%
2021-12-31 $2.40 Billion -2.97%
2020-12-31 $2.47 Billion +7.09%
2019-12-31 $2.31 Billion -5.79%
2018-12-31 $2.45 Billion -5.36%
2017-12-31 $2.59 Billion -6.38%
2016-12-31 $2.77 Billion -1.18%
2015-12-31 $2.80 Billion +120.84%
2014-12-31 $1.27 Billion -8.90%
2013-12-31 $1.39 Billion +380.11%
2012-12-31 $289.83 Million +26.29%
2011-12-31 $229.49 Million +194.80%
2010-12-31 $77.85 Million -10.96%
2009-12-31 $87.43 Million +301.72%
2008-12-31 $21.76 Million -45.00%
2007-12-31 $39.57 Million +352.10%
2006-12-31 $8.75 Million -2.76%
2005-12-31 $9.00 Million -10.63%
2004-12-31 $10.07 Million -11.21%
2003-12-31 $11.34 Million -35.24%
2002-12-31 $17.52 Million -36.60%
2001-12-31 $27.62 Million -26.09%
2000-12-31 $37.38 Million +732.29%
1999-12-31 $4.49 Million -41.68%
1998-12-31 $7.70 Million +175.00%
1997-12-31 $2.80 Million -28.21%
1996-12-31 $3.90 Million -40.00%
1995-12-31 $6.50 Million --

About Opko Health Inc

NASDAQ:OPK USA Diagnostics & Research
Market Cap
$844.47 Million
Market Cap Rank
#9885 Global
#2539 in USA
Share Price
$1.10
Change (1 day)
-2.22%
52-Week Range
$1.10 - $1.58
All Time High
$11.91
About

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, m… Read more